Copyright Reports & Markets. All rights reserved.

Global Complement Protein C5 Inhibitors Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Complement Protein C5 Inhibitors Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Oral Administration
    • 1.3.3 Intravenous Injection
    • 1.3.4 Subcutaneous Administration
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Complement Protein C5 Inhibitors Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Paroxysmal Nocturnal Hemoglobinuria (PNH)
    • 1.4.3 Atypical Hemolytic Uremic Syndrome (aHUS)
    • 1.4.4 Neuromyelitis Optica Spectrum Disorde (NMOSD)
    • 1.4.5 Geographic Atrophy (GA)
    • 1.4.6 Others
  • 1.5 Global Complement Protein C5 Inhibitors Market Size & Forecast
    • 1.5.1 Global Complement Protein C5 Inhibitors Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Complement Protein C5 Inhibitors Sales Quantity (2021-2032)
    • 1.5.3 Global Complement Protein C5 Inhibitors Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 UCB
    • 2.1.1 UCB Details
    • 2.1.2 UCB Major Business
    • 2.1.3 UCB Complement Protein C5 Inhibitors Product and Services
    • 2.1.4 UCB Complement Protein C5 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 UCB Recent Developments/Updates
  • 2.2 Regeneron Pharmaceuticals
    • 2.2.1 Regeneron Pharmaceuticals Details
    • 2.2.2 Regeneron Pharmaceuticals Major Business
    • 2.2.3 Regeneron Pharmaceuticals Complement Protein C5 Inhibitors Product and Services
    • 2.2.4 Regeneron Pharmaceuticals Complement Protein C5 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Regeneron Pharmaceuticals Recent Developments/Updates
  • 2.3 Astellas Pharma
    • 2.3.1 Astellas Pharma Details
    • 2.3.2 Astellas Pharma Major Business
    • 2.3.3 Astellas Pharma Complement Protein C5 Inhibitors Product and Services
    • 2.3.4 Astellas Pharma Complement Protein C5 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Astellas Pharma Recent Developments/Updates
  • 2.4 Alexion Pharmaceuticals
    • 2.4.1 Alexion Pharmaceuticals Details
    • 2.4.2 Alexion Pharmaceuticals Major Business
    • 2.4.3 Alexion Pharmaceuticals Complement Protein C5 Inhibitors Product and Services
    • 2.4.4 Alexion Pharmaceuticals Complement Protein C5 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Alexion Pharmaceuticals Recent Developments/Updates
  • 2.5 Roche
    • 2.5.1 Roche Details
    • 2.5.2 Roche Major Business
    • 2.5.3 Roche Complement Protein C5 Inhibitors Product and Services
    • 2.5.4 Roche Complement Protein C5 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Roche Recent Developments/Updates
  • 2.6 Amgen
    • 2.6.1 Amgen Details
    • 2.6.2 Amgen Major Business
    • 2.6.3 Amgen Complement Protein C5 Inhibitors Product and Services
    • 2.6.4 Amgen Complement Protein C5 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Amgen Recent Developments/Updates
  • 2.7 Samsung Bioepis
    • 2.7.1 Samsung Bioepis Details
    • 2.7.2 Samsung Bioepis Major Business
    • 2.7.3 Samsung Bioepis Complement Protein C5 Inhibitors Product and Services
    • 2.7.4 Samsung Bioepis Complement Protein C5 Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Samsung Bioepis Recent Developments/Updates

3 Competitive Environment: Complement Protein C5 Inhibitors by Manufacturer

  • 3.1 Global Complement Protein C5 Inhibitors Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Complement Protein C5 Inhibitors Revenue by Manufacturer (2021-2026)
  • 3.3 Global Complement Protein C5 Inhibitors Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Complement Protein C5 Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Complement Protein C5 Inhibitors Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Complement Protein C5 Inhibitors Manufacturer Market Share in 2025
  • 3.5 Complement Protein C5 Inhibitors Market: Overall Company Footprint Analysis
    • 3.5.1 Complement Protein C5 Inhibitors Market: Region Footprint
    • 3.5.2 Complement Protein C5 Inhibitors Market: Company Product Type Footprint
    • 3.5.3 Complement Protein C5 Inhibitors Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Complement Protein C5 Inhibitors Market Size by Region
    • 4.1.1 Global Complement Protein C5 Inhibitors Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Complement Protein C5 Inhibitors Consumption Value by Region (2021-2032)
    • 4.1.3 Global Complement Protein C5 Inhibitors Average Price by Region (2021-2032)
  • 4.2 North America Complement Protein C5 Inhibitors Consumption Value (2021-2032)
  • 4.3 Europe Complement Protein C5 Inhibitors Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Complement Protein C5 Inhibitors Consumption Value (2021-2032)
  • 4.5 South America Complement Protein C5 Inhibitors Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Complement Protein C5 Inhibitors Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Complement Protein C5 Inhibitors Sales Quantity by Type (2021-2032)
  • 5.2 Global Complement Protein C5 Inhibitors Consumption Value by Type (2021-2032)
  • 5.3 Global Complement Protein C5 Inhibitors Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Complement Protein C5 Inhibitors Sales Quantity by Application (2021-2032)
  • 6.2 Global Complement Protein C5 Inhibitors Consumption Value by Application (2021-2032)
  • 6.3 Global Complement Protein C5 Inhibitors Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Complement Protein C5 Inhibitors Sales Quantity by Type (2021-2032)
  • 7.2 North America Complement Protein C5 Inhibitors Sales Quantity by Application (2021-2032)
  • 7.3 North America Complement Protein C5 Inhibitors Market Size by Country
    • 7.3.1 North America Complement Protein C5 Inhibitors Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Complement Protein C5 Inhibitors Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Complement Protein C5 Inhibitors Sales Quantity by Type (2021-2032)
  • 8.2 Europe Complement Protein C5 Inhibitors Sales Quantity by Application (2021-2032)
  • 8.3 Europe Complement Protein C5 Inhibitors Market Size by Country
    • 8.3.1 Europe Complement Protein C5 Inhibitors Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Complement Protein C5 Inhibitors Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Complement Protein C5 Inhibitors Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Complement Protein C5 Inhibitors Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Complement Protein C5 Inhibitors Market Size by Region
    • 9.3.1 Asia-Pacific Complement Protein C5 Inhibitors Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Complement Protein C5 Inhibitors Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Complement Protein C5 Inhibitors Sales Quantity by Type (2021-2032)
  • 10.2 South America Complement Protein C5 Inhibitors Sales Quantity by Application (2021-2032)
  • 10.3 South America Complement Protein C5 Inhibitors Market Size by Country
    • 10.3.1 South America Complement Protein C5 Inhibitors Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Complement Protein C5 Inhibitors Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Complement Protein C5 Inhibitors Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Complement Protein C5 Inhibitors Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Complement Protein C5 Inhibitors Market Size by Country
    • 11.3.1 Middle East & Africa Complement Protein C5 Inhibitors Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Complement Protein C5 Inhibitors Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Complement Protein C5 Inhibitors Market Drivers
  • 12.2 Complement Protein C5 Inhibitors Market Restraints
  • 12.3 Complement Protein C5 Inhibitors Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Complement Protein C5 Inhibitors and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Complement Protein C5 Inhibitors
  • 13.3 Complement Protein C5 Inhibitors Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Complement Protein C5 Inhibitors Typical Distributors
  • 14.3 Complement Protein C5 Inhibitors Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Complement Protein C5 Inhibitors market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Complement protein C5 inhibitors are drugs that block the activity of complement protein C5, a key component of the immune system's complement pathway. By inhibiting C5, these drugs prevent the formation of C5a and C5b. This reduces immune-mediated damage in diseases like paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica spectrum disorder (NMOSD).
    This report is a detailed and comprehensive analysis for global Complement Protein C5 Inhibitors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Complement Protein C5 Inhibitors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Complement Protein C5 Inhibitors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Complement Protein C5 Inhibitors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Complement Protein C5 Inhibitors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Complement Protein C5 Inhibitors
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Complement Protein C5 Inhibitors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UCB, Regeneron Pharmaceuticals, Astellas Pharma, Alexion Pharmaceuticals, Roche, Amgen, Samsung Bioepis, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Complement Protein C5 Inhibitors market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Oral Administration
    Intravenous Injection
    Subcutaneous Administration
    Market segment by Application
    Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Atypical Hemolytic Uremic Syndrome (aHUS)
    Neuromyelitis Optica Spectrum Disorde (NMOSD)
    Geographic Atrophy (GA)
    Others
    Major players covered
    UCB
    Regeneron Pharmaceuticals
    Astellas Pharma
    Alexion Pharmaceuticals
    Roche
    Amgen
    Samsung Bioepis
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Complement Protein C5 Inhibitors product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Complement Protein C5 Inhibitors, with price, sales quantity, revenue, and global market share of Complement Protein C5 Inhibitors from 2021 to 2026.
    Chapter 3, the Complement Protein C5 Inhibitors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Complement Protein C5 Inhibitors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Complement Protein C5 Inhibitors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Complement Protein C5 Inhibitors.
    Chapter 14 and 15, to describe Complement Protein C5 Inhibitors sales channel, distributors, customers, research findings and conclusion.

    Buy now